BE702023A - - Google Patents

Info

Publication number
BE702023A
BE702023A BE702023DA BE702023A BE 702023 A BE702023 A BE 702023A BE 702023D A BE702023D A BE 702023DA BE 702023 A BE702023 A BE 702023A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE702023A publication Critical patent/BE702023A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE702023D 1966-07-29 1967-07-28 BE702023A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB23066/67A GB1202521A (en) 1966-07-29 1966-07-29 01beta-CHLORO-19-NOR-STEROIDS
GB3427566 1966-07-29

Publications (1)

Publication Number Publication Date
BE702023A true BE702023A (fr) 1968-01-29

Family

ID=26256295

Family Applications (1)

Application Number Title Priority Date Filing Date
BE702023D BE702023A (fr) 1966-07-29 1967-07-28

Country Status (12)

Country Link
JP (2) JPS5021469B1 (fr)
AT (2) AT311564B (fr)
BE (1) BE702023A (fr)
CH (2) CH580644A5 (fr)
DE (1) DE1668124B2 (fr)
DK (2) DK129004B (fr)
FR (2) FR1565340A (fr)
GB (1) GB1202521A (fr)
IL (1) IL28411A (fr)
NL (1) NL6710459A (fr)
PL (1) PL79253B1 (fr)
SE (2) SE349025B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2034479A1 (fr) * 1969-01-23 1970-12-11 Glaxo Lab Ltd
FR2059570A1 (fr) * 1969-07-25 1971-06-04 Glaxo Lab Ltd

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5090183A (fr) * 1973-12-14 1975-07-19
JPS5090184A (fr) * 1973-12-14 1975-07-19

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2034479A1 (fr) * 1969-01-23 1970-12-11 Glaxo Lab Ltd
FR2059570A1 (fr) * 1969-07-25 1971-06-04 Glaxo Lab Ltd

Also Published As

Publication number Publication date
SE350488B (fr) 1972-10-30
AT301766B (de) 1972-09-25
DE1668124B2 (de) 1976-10-07
DE1668124A1 (de) 1971-05-06
PL79253B1 (fr) 1975-06-30
DK131295B (da) 1975-06-23
JPS5021469B1 (fr) 1975-07-23
FR7812M (fr) 1970-05-20
IL28411A (en) 1972-07-26
DK129004B (da) 1974-08-05
JPS5224013B1 (fr) 1977-06-28
AT311564B (de) 1973-11-26
NL6710459A (fr) 1968-01-30
CH580644A5 (fr) 1976-10-15
DK131295C (fr) 1975-11-17
CH584724A5 (fr) 1977-02-15
FR1565340A (fr) 1969-05-02
GB1202521A (en) 1970-08-19
SE349025B (fr) 1972-09-18

Similar Documents

Publication Publication Date Title
DK131295C (fr)
AU5917865A (fr)
AU428063B2 (fr)
AU424443B2 (fr)
AU433222B2 (fr)
AU414526B2 (fr)
AU421822B2 (fr)
AU415165B1 (fr)
AU417216B2 (fr)
AU612166A (fr)
AU5895065A (fr)
AU1111066A (fr)
AU1144366A (fr)
AU6703465A (fr)
AU218666A (fr)
BE694507A (fr)
BE692877A (fr)
BE694494A (fr)
BE694243A (fr)
BE694030A (fr)
AU433620A (fr)
AU415780B2 (fr)
BE692841A (fr)
AU6852465A (fr)
AU414093B2 (fr)